| Literature DB >> 24919070 |
Jessie J Wang1, Anastasia Ivanova.
Abstract
The sequential parallel comparison design (SPCD) is a two-stage design recommended for trials with possibly high placebo response. A drug-placebo comparison in the first stage is followed in the second stage by placebo nonresponders being re-randomized between drug and placebo. We describe how SPCD can be used in trials where multiple doses of a drug or multiple treatments are compared with placebo and present two adaptive approaches. We detail how to analyze data in such trials and give recommendations about the allocation proportion to placebo in the two stages of SPCD.Entities:
Keywords: Adaptive design; Dose-finding; Phase 2; Placebo response; SPCD; Sequential parallel comparison design
Mesh:
Substances:
Year: 2014 PMID: 24919070 DOI: 10.1080/10543406.2014.924960
Source DB: PubMed Journal: J Biopharm Stat ISSN: 1054-3406 Impact factor: 1.051